10 results
Primary Objective: Further delineation of the natural history and phenotype/genotype relation of vEDS pateints with a heterozygous pathogenic variant in the COL3A1 gene. Secondary Objectives: 1. reasons for referral for genetic analysis; 2. all…
The primary objectives are to evaluate:-The effect of inclisiran treatment on the proportion of subjects achieving prespecified low densitylipoprotein cholesterol (LDL-C) targets at end of study (EOS)-The safety and tolerability profile of long term…
To identify arrhythmogenic electromechanical risk profiles in LQTS patients; in baseline conditions and during provocation; the recognition of risk profiles will improve risk stratification for sudden cardiac death.
Primary objective of this trial is to investigate in a double blind randomized controlled trial in children undergoing open heart surgery if NO exposure during CPB reduces the postoperative duration of invasive mechanical ventilation (defined as…
The primary objective is to evaluate the safety and effectiveness of the PULSTA TPV System for the treatment of congenital or acquired heart disease with pulmonary valve disease and to gain data that will lead to CE mark approval for the PULSTA TPV…
To investigate whether the menstrual cycle influences diagnostics in patients with cardiovascular disease
This study will focus on the long-term outcome after surgical correction of several congenital heart defects in a non-selected cohort. The repetitive nature of this study will make it possible to analyze specific changes in cardiac function over…
The aim of the proposed randomized controlled trial (RCT) is to determine the effectiveness, and related healthcare costs of a mHealth-based targeted clinical monitoring pathway in GUCH patients. The primary research question is to assess the effect…
This study has been transitioned to CTIS with ID 2022-502858-14-00 check the CTIS register for the current data. primary objective:To assess the long-term safety and tolerability of mavacamten in participants with hypertrophic cardiomyopathy (HCM)…
Describe the electrocardiographic changes and areas of late myocardial activation encountered in PLN and PKP2 mutation carriers during ajmaline provocation and the relation of these differences to the development for early stages of arrhythmogenic…